Cover Image

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

Abstract In this exploratory study from a randomized double‐blinded crossover trial including 70 patients with coronary heart disease and self‐perceived muscular side effects of statins, we aimed to determine the relationship between low‐density lipoprotein cholesterol (LDL‐C) reduction and atorvast...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. Sverre (Author), J. Munkhaugen (Author), O. Kristiansen (Author), H. Weedon‐Fekjær (Author), K. Peersen (Author), E. Gjertsen (Author), L. Gullestad (Author), S. Bergan (Author), E. Husebye (Author), N. T. Vethe (Author)
Format:	Book
Published:	Wiley, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease
by: Trine Lauritzen, et al.
Published: (2024)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
by: Mostafa Najafipour, et al.
Published: (2018)

The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
by: Dario Lehoux, et al.
Published: (2023)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
by: Shou-Yu Chu, et al.
Published: (2019)

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b for cardiovascular risk assessment - What is the right choice?
by: Shrikanth N Hegde
Published: (2020)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020)

Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and kidney stone: evidence from NHANES 2007-2018
by: Tao Chen, et al.
Published: (2024)

Triglycerides and high-density lipoprotein cholesterol are associated with insulinemia in adolescents
by: Ramírez-López Guadalupe, et al.
Published: (2006)

High -density lipoprotein cholesterol as a predictor for diabetes mellitus
by: Hong Wu, et al.
Published: (2018)

Do high-density lipoprotein cholesterol levels really reflect cardioprotection?
by: Vaishali Venkatesh Dhat, et al.
Published: (2023)

Negative Association of Plasma Cholesterol and Low-density Lipoprotein Cholesterol, but not Testosterone or Growth Hormone, with Bone Mineral Density in Elderly Korean Men
by: Dong Jun SUNG, et al.
Published: (2016)

Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders
by: S. A. Shalnova, et al.
Published: (2022)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020)

GENETICALLY PREDICTED LIPOPROTEIN(A) IS ASSOCIATED WITH CORONARY ARTERY PLAQUE SEVERITY INDEPENDENT OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL
by: Shoa L. Clarke, MD, PhD
Published: (2024)

Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome.
by: Hope H Biswas, et al.
Published: (2015)

Non-High-Density lipoprotein cholesterol or Apolipoprotein B in the prediction of myocardial infarction
by: Amit Kumar Pradhan, et al.
Published: (2017)

The triglyceride-to-high density lipoprotein cholesterol ratio in overweight Korean children and adolescents
by: Dong-Yoon Yoo, et al.
Published: (2017)

Association of adiposity and fitness with triglyceride-to-high-density lipoprotein cholesterol ratio in youth
by: Danladi Ibrahim Musa, et al.
Published: (2023)

Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the manic state of bipolar disorder
by: Yusuf Çokünlü, et al.
Published: (2021)

Monte Carlo simulations to meet the ESC recommended low-density lipoprotein cholesterol targets
by: Salil V. Deo
Published: (2023)

The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach
by: Ge Liu, et al.
Published: (2023)

Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol
by: Yonghong Luo MD, et al.
Published: (2023)

Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis
by: Gotto Antonio M, et al.
Published: (2009)

Significance of Decreased Serum High-density Lipoprotein Cholesterol Levels in Patients with Gastric Cancer
by: Tae Ho Kim
Published: (2022)

Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab
by: Funda Tamer, et al.
Published: (2023)

Comparison of direct low density lipoprotein cholesterol measurement with the Friedewald formula and alternative formulas
by: Nilgun Isiksacan, et al.
Published: (2023)

Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham Heart Study data
by: Tanaka Toshiko, et al.
Published: (2010)

Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Gastrointestinal Involvement of Immunoglobulin a Vasculitis
by: Shao X, et al.
Published: (2023)

Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis
by: Xishao Xie, et al.
Published: (2017)

The Global Burden of Diseases attributed to high low-density lipoprotein cholesterol from 1990 to 2019
by: Jia Zheng, et al.
Published: (2022)

Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023)

Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio
by: Kurtkulagi Ozge, et al.
Published: (2021)

Possibilities of using rosuvastatin to achieve target level of low-density lipoprotein cholesterol in clinical practice
by: Yuliia A. Prus, et al.
Published: (2020)

Serum Low-Density Lipoprotein Cholesterol Levels are Associated with Relapse in Neuromyelitis Optica Spectrum Disorder
by: Ding J, et al.
Published: (2024)

Jogging and weight training associated with increased high-density lipoprotein cholesterol levels in Taiwanese adults
by: Chien-Chang Ho, et al.
Published: (2022)

Combined associations of cardiorespiratory fitness and grip strength with non-high-density lipoprotein cholesterol concentrations among Japanese children and adolescents
by: Tetsuhiro Kidokoro, et al.
Published: (2020)

U-Shaped Association of High-Density Lipoprotein Cholesterol with All-Cause and Cardiovascular Mortality in Hypertensive Population
by: Chen C, et al.
Published: (2020)

Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol
by: Hao Jin, et al.
Published: (2024)